Jaspr Health, which is testing its scientifically-validated, suicide-specific digital care platform, expanded its pilot program in emergency departments to primary care settings. The platform is being piloted in nearly 20 emergency departments, including 12 Allina Health emergency departments in Minnesota and Western Wisconsin area. The expansion to primary care clinics, as well as to individuals with alcohol use disorder, is funded by a $2.1 million grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
Jaspr Health was developed by the Evidence-Based Practice Institute, Inc. The platform uses a tablet and mobile application that provide on-demand guided assessments and interventions, such as crisis stability planning. The goal is to improve capacity for suicide risk assessment and to accelerate access to evidence-based assessments and interventions. The platform integrates with electronic health records.
In clinical trials funded by the National Institute of Health, Jaspr outperformed traditional care in emergency department settings. It increased access to evidence-based, suicide-specific interventions, increased consumer ability to cope with suicidal thoughts, decreased consumer distress and agitation. Consumers also reported that the platform helped them learn emotional regulation skills.
In August 2021, Jaspr Health entered a relationship with the Zero Suicide Institute to integrate awareness, education, and support. During the fall of 2021, the two organizations plan to jointly launch new educational programs and content for health systems highlighting how digital technology can significantly improve the standardization of compassionate, personalized, and evidence-based care.
The clinical trial findings were reported in “Using a Tablet-Based App to Deliver Evidence-Based Practices for Suicidal Patients in the Emergency Department: Pilot Randomized Controlled Trial,” which published in March 2021, in JMIR Mental Health. A free abstract is posted at https://mental.jmir.org/2021/3/e23022 (accessed October 19, 2021).
More information about the clinical trial is posted at https://clinicaltrials.gov/ct2/show/NCT03584386 (accessed October 19, 2021).
This was reported by Jaspr Health on October 13, 2021.
Contact information: Marcus Kako, Marketing, Jaspr Health, Evidence-Based Practice Institute, Inc., Northwest Work Lofts, 3131 Western Ave., Suite 414, Seattle, Washington 98121; 707-637-6797; Email: firstname.lastname@example.org; Website: https://jasprhealth.com/contact/